Retinal
Implant Market study is providing you with the up-to-date,
actionable market information and projections with the latest impact of the
Covid 19 outbreak. It offers all the requisite data to support tactical
business decisions and come up with strategic growth plans. This study also
proposes a comprehensive insight into the development policies and plans in
addition to manufacturing processes and cost structures.
Global Retinal Implant
Market is expected to reach USD 74.7 million by 2026. A retinal implant is also
termed as “the Argus® II retinal prosthesis system” or “bionic eye”. These
implantable devices are planned to supplant photo transduction within the eyes
of persons with major retinal illnesses such as age-related macular
degeneration or retinitis pigmentosa. The retinal implant market is estimated
to grow at a CAGR of 10.6% over the forecast period as the scope and its
applications are rising enormously across the globe.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/retinal-implant-market/request-sample
The factors that are
playing a major role in the growth of retinal implant market are rising
occurrence of degenerative conditions, increasing disposable income in emerging
countries, growing aging population, and development of enhanced and efficient
technology. However, the high cost of research, lack of trained personnel's,
and development and lack of medical reimbursement are the factors that may
restrain overall market growth in the years to come. Retinal implant industry
is segmented based on type, device type, application, and region.
Suprachoroidal implants,
epiretinal implants, and subretinal implants are the types that could be
explored in the retinal implant in the forecast period. Alpha IMS, Argus II,
and an implantable telescope are the device types that could be explored in the
retinal implant in the forecast period.
The market may be
categorized based on applications like total blindness, retinal degenerative
diseases, and others that could be explored in the forecast period. The retinal
degenerative sector accounted for the substantial market share of the retinal
implant and is estimated to lead the overall market in the years to come.
Globally, North America
accounted for the significant market share of the retinal implant and is
estimated to lead the overall market in the years to come. The reason behind
the overall market growth could be developed infrastructure, growing
eye-related diseases, and rising use of technologically enhanced devices. The
United States is a major consumer of the retinal implant in this region.
Instead, Europe and the Asia Pacific are also estimated to have a positive
influence on the future growth.
Europe is the second
largest region with significant market share. However, Asia Pacific is
estimated to grow at the highest CAGR in the forecast period. The aspects that
may be ascribed to the growth comprise growing geriatric population, growing
awareness among consumers regarding eye care, growing number of patients
suffering from retinitis pigmentosa (RP) and age-related macular degeneration
(AMD), and developing healthcare infrastructure. The developing countries like
India and China are the major consumers of the retinal implant in this region.
The key players of retinal
implant market are Philips Healthcare, Second Sight Medical Products, Inc.,
Hamilton Medical AG, Retina Implant AG, Bionic Vision Australia, Dräger Medical
GmbH, VisionCare Ophthalmic Technologies, Inc., Visus Technology, Inc., and
Abbott Vascular, Bionic Eye Technologies, Inc. These players are concentrating
on inorganic growth to sustain themselves amidst fierce competition.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment